Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.

Yildiz, IbrahimEkenel, MeltemAltman, TuleyKocar, MuharremUysal, MukreminKanitez, MetinBayoglu, Vedat2024-04-242024-04-2420140732-183X1527-7755https://doi.org/10.1200/jco.2014.32.15_suppl.e15602https://hdl.handle.net/11468/1828350th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2014 -- Chicago, IL[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.Conference Object3215WOS:00035861320074010.1200/jco.2014.32.15_suppl.e15602Q1